Characteristic | Overall Series | NAFLD Patients | Controls | ||||||
---|---|---|---|---|---|---|---|---|---|
Carriers (n = 212) | Non-Carriers (n = 109) | P Value | Carriers (n = 106) | Non-Carriers (n = 40) | P Value | Carriers (n = 106) | Non-Carriers (n = 69) | P Value | |
Female, % | 97 (45.8) | 55 (50.5) | 0.424 | 44 (41.5) | 21 (52.5) | 0.233 | 53 (50) | 34 (49.3) | 0.925 |
Age, y | 60.70 ± 13.79 | 60.08 ± 13.84 | 0.704 | 60.94 ± 15.60 | 61.39 ± 16.10 | 0.874 | 60.48 ± 11.90 | 59.64 ± 12.11 | 0.650 |
BMI, kg/m2 | 24.53 ± 4.29 | 24.26 ± 3.48 | 0.566 | 27.01 ± 4.22 | 26.74 ± 2.84 | 0.696 | 22.19 ± 2.79 | 22.83 ± 2.99 | 0.157 |
ALT, U/L | 26.71 ± 21.78 | 23.97 ± 15.29 | 0.243 | 29.82 ± 17.00 | 30.23 ± 19.41 | 0.900 | 23.77 ± 25.21 | 19.82 ± 9.90 | 0.217 |
AST, U/L | 23.68 ± 11.74 | 23.23 ± 10.92 | 0.738 | 24.12 ± 8.60 | 24.46 ± 10.02 | 0.836 | 23.27 ± 14.11 | 22.28 ± 11.24 | 0.623 |
GGT, U/L | 36.53 ± 37.60 | 29.64 ± 20.11 | 0.035 | 41.06 ± 27.28 | 36.08 ± 24.46 | 0.304 | 32.26 ± 44.95 | 25.42 ± 15.25 | 0.151 |
ALP, U/L | 73.09 ± 20.44 | 71.19 ± 23.03 | 0.452 | 71.59 ± 15.08 | 69.60 ± 20.09 | 0.516 | 74.51 ± 24.43 | 72.58 ± 24.46 | 0.611 |
TG, mmol/L | 1.65 ± 1.17 | 1.49 ± 0.91 | 0.233 | 1.95 ± 1.35 | 1.83 ± 1.21 | 0.609 | 1.36 ± 0.87 | 1.28 ± 0.54 | 0.515 |
TC, mmol/L | 4.71 ± 1.39 | 4.94 ± 1.78 | 0.142 | 5.44 ± 0.82 | 5.54 ± 0.84 | 0.535 | 4.57 ± 1.20 | 4.03 ± 1.47 | 0.008 |
HDL, mmol/L | 1.26 ± 0.29 | 1.25 ± 0.35 | 0.721 | 1.20 ± 0.20 | 1.19 ± 0.24 | 0.923 | 1.32 ± 0.34 | 1.27 ± 0.40 | 0.376 |
LDL, mmol/L | 3.17 ± 0.65 | 2.94 ± 0.72 | 0.003 | 3.23 ± 0.51 | 2.88 ± 0.54 | 0.056 | 3.12 ± 0.76 | 3.08 ± 0.59 | 0.705 |
TBIL, umol/L | 12.90 ± 4.67 | 13.55 ± 5.47 | 0.268 | 12.72 ± 4.39 | 14.16 ± 5.18 | 0.092 | 13.06 ± 4.94 | 13.20 ± 5.56 | 0.860 |
FPG, mmol/L | 5.16 ± 1.67 | 4.94 ± 1.18 | 0.225 | 5.74 ± 2.12 | 5.35 ± 1.37 | 0.272 | 4.61 ± 0.77 | 4.67 ± 0.94 | 0.656 |